Skip to main content

Table 2 Influence of RAMP-O on composite milk NAGase

From: Therapeutic effect of polysaccharide fraction of Atractylodis macrocephalae Koidz. in bovine subclinical mastitis

RAMP-O (mg) No. of cows Weeks post treatment
0 1 2 3
16 6 52.07 ± 12.50 46.75 ± 10.09* 46.31 ± 9.79* 33.91 ± 9.27a*
32 6 52.46 ± 12.24 46.18 ± 9.49* 25.36 ± 6.77A** 23.79 ± 5.47A**
48 6 52.11 ± 11.35 27.27 ± 8.09A** 24.97 ± 6.85A** 21.09 ± 3.44A**
Control 6 52.66 ± 12.12 52.90 ± 12.07 55.09 ± 11.73 53.13 ± 11.81
  1. NAGase of composite milk in cows before and after subcutaneous injection of RAMP-O in the areas of supramammary lymph node (mean ± S.E. U/L)
  2. aP < 0.05, AP < 0.01, compared with the control in the same time
  3. *P < 0.05, **P < 0.01, compared with pretreatment
  4. Pretreatment